TherapeuticsMD (TXMD) Other Non-Current Assets (2010 - 2026)

TherapeuticsMD (TXMD) has reported Other Non-Current Assets for 17 consecutive years, with $395000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Assets fell 7.71% year-over-year to $395000.0; the trailing twelve-month figure through Jun 2026 stood at $395000.0 (down 7.71% YoY), and the FY2025 full-year result was $444000.0, up 241.54% from the prior year.
• Other Non-Current Assets eased to $395000.0 in Q2 2026 per TXMD's latest filing, from $419000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $470000.0 in Q3 2025 and bottomed at $58000.0 in Q2 2024.
• Historically, Other Non-Current Assets has averaged $268055.6 across 5 years, with a median of $253500.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets plunged 99.48% in 2022, then soared 710.34% in 2025.
• Over 5 years, Other Non-Current Assets stood at $253000.0 in 2022, then soared by 35.97% to $344000.0 in 2023, then tumbled by 62.21% to $130000.0 in 2024, then surged by 241.54% to $444000.0 in 2025, then slipped by 11.04% to $395000.0 in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $395000.0, $419000.0, and $444000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.